An alkyne-appended, click-ready Pt(II) complex with an unusual arrangement in the solid state.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Angewandte Chemie

• Publication date

  2015-01-12

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/anie.201409853PMID 25429919
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platinum-RNA Modifications Following Drug Treatment in S. cerevisiae Identified by Click Chemistry and Enzymatic Mapping

  2014cited by this paper
• Assembly of Platinum Diimine Dithiolate Complexes onto Hydrogen-Terminated Silicon Surfaces

  2014cited by this paper
• Investigating the cellular fate of a DNA-targeted platinum-based anticancer agent by orthogonal double-click chemistry

  2014cited by this paper
• Using fluorescent post-labeling to probe the subcellular localization of DNA-targeted platinum anticancer agents.

  2013cited by this paper
• Derivatisation of an Anti-Cancer Cationic Antimicrobial Peptide and its Complexation to Platinum(II)

  2013cited by this paper
• Steering On-Surface Self-Assembly of High-Quality Hydrocarbon Networks with Terminal Alkynes

  2013cited by this paper
• Targeting mitochondrial DNA with a platinum-based anticancer agent.

  2013cited by this paper
• Picazoplatin, an azide-containing platinum(II) derivative for target analysis by click chemistry.

  2013cited by this paper
• Targeted therapy vs. DNA-adduct formation-guided design: thoughts about the future of metal-based anticancer drugs.

  2012cited by this paper
• Calixarenes with dansyl groups as potential chemosensors

  2012cited by this paper
• Cellular interactions of platinum drugs

  2012cited by this paper
• Interactions of anticancer Pt compounds with proteins: an overlooked topic in medicinal inorganic chemistry?

  2012cited by this paper
• 4-aminoquinoline analogues and its platinum (II) complexes as antimalarial agents.

  2011cited by this paper
• A fluorescent probe for fast and quantitative detection of hydrogen sulfide in blood.

  2011cited by this paper
• Advances in platinum chemotherapeutics.

  2010cited by this paper
• Efficient synthesis of 1-sulfonyl-1,2,3-triazoles.

  2010cited by this paper
• Site-Selective Ser-Hydrolase Labelling with a Luminescent Organometallic NCN–Platinum Complex

  2010cited by this paper
• Photoaffinity Isolation and Identification of Proteins in Cancer Cell Extracts that Bind to Platinum‐Modified DNA

  2009cited by this paper
• Cytoplasmic initiation of cisplatin cytotoxicity.

  2008cited by this paper
• Ethynyl Group as a Supramolecular Halogen and C≡C−H···C≡C Trimer Synthon in 2,4,6-Tris(4-ethynylphenoxy)-1,3,5-triazine

  2007cited by this paper
• Copper-catalyzed synthesis of N-sulfonyl-1,2,3-triazoles: controlling selectivity.

  2007cited by this paper
• Practical synthesis of amides from in situ generated copper(I) acetylides and sulfonyl azides.

  2006cited by this paper
• Reactivity of silyl-substituted heterobimetallic iron–platinum hydride complexes: Part III. Alkyne insertions into the platinum–hydride bond and competition between μ-vinylidene and dimetallacyclopentenone formation

  2006cited by this paper
• Metal-based antitumour drugs in the post genomic era.

  2006cited by this paper
• Copper-catalyzed hydrative amide synthesis with terminal alkyne, sulfonyl azide, and water.

  2005cited by this paper
• Cellular processing of platinum anticancer drugs

  2005cited by this paper
• CH/π hydrogen bonds in crystals

  2004cited by this paper
• Cisplatin and platinum drugs at the molecular level. (Review).

  2003cited by this paper
• Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

  1999cited by this paper
• Convenient and Simplified Approaches to N-Monoprotected Triaminopropane Derivatives: Key Intermediates for Bifunctional Chelating Agent Synthesis

  1998cited by this paper
• C–H···π interactions inethynylbenzenes: the crystal structures of ethynylbenzene and1,3,5-triethynylbenzene, and a redetermination of the structure of1,4-diethynylbenzene

  1997cited by this paper
• CH···π versus CH···Halogen interactions—the crystal structures of the 4-halogenoethynylbenzenes

  1997cited by this paper
• Weak hydrogen bonding. Part 5. Experimental evidence for the long-range nature of CC–H ⋯π interactions: crystallographic and spectroscopic studies of three terminal alkynes

  1996cited by this paper
• Weak hydrogen bonding. Part 2. The hydrogen bonding nature of short C–H ⋯π contacts: crystallographic, spectroscopic and quantum mechanical studies of some terminal alkynes

  1995cited by this paper
• Cooperative CC–H ⋯ CC–H interactions: crystal structure of DL-prop-2-ynylglycine and database study of terminal alkynes

  1995cited by this paper
• Binding Characteristics of (–)‐(R)‐2‐Aminomethylpyrrolidine(1,1‐cyclobutanedi‐carboxylato)‐2‐platinum(II) to DNA, RNA and Protein Molecules in HeLa Cells and Its Lethal Effect: Comparison with cis‐ and trans‐Diammmedichloroplatinums(II)

  1994cited by this paper
• The Number of Platinum Atoms Binding to DNA, RNA and Protein Molecules of HeLa Cells Treated with Cisplatin at Its Mean Lethal Concentration

  1992cited by this paper
• The preparation and properties of compounds containing Pt(III)

  1985cited by this paper
• Clinical and pharmacological studies with cis-diamminedichloroplatinum (II).

  1973cited by this paper

• Luminescent transition metal complexes for functional food quality and safety: Analysis of bioactive constituents and contaminants

  2026cites this paper
• Designing for Intramolecular H-Bonding in Palladium(II) Dichlorides.

  2025cites this paper
• Icaritin Ameliorates Cisplatin‐Induced Mitochondrial Metabolic Dysfunction‐Associated Nephrotoxicity and Synergistically Potentiates Its Antitumor Efficacy

  2025cites this paper
• Novel Platinum(II) Tetrazine Complex Capable of Live‐Cell IEDDA Reaction

  2025cites this paper
• A trackable trinuclear platinum complex for breast cancer treatment

  2025cites this paper
• Click-Capable Phenanthriplatin Derivatives as Tools to Study Pt(II)-Induced Nucleolar Stress

  2024cites this paper
• In Vitro Binding of Platinum Anticancer Drugs to DNA Observed Directly by Polyacrylamide Gel Electrophoresis: A Multiweek Undergraduate Laboratory Investigation

  2023cites this paper
• Comparison of click-capable oxaliplatin and cisplatin derivatives to better understand Pt(ii)-induced nucleolar stress

  2023cites this paper
• A new supramolecular bonding motif involving NH bonds of ammonium salts and macrocycles derived from platinum corners and butadiynediyl linkers.

  2022cites this paper
• Clickable Cisplatin Derivatives as Versatile Tools to Probe the DNA Damage Response to Chemotherapy

  2022cites this paper
• Approaches towards understanding the mechanism-of-action of metallodrugs

  2021cites this paper
• Exploiting azide–alkyne click chemistry in the synthesis, tracking and targeting of platinum anticancer complexes

  2020cites this paper
• N-Sulfonyl acetylketenimine as a highly reactive intermediate for synthesis of N-Aroylsulfonamides

  2019cites this paper
• The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

  2016cites this paper
• Multifunctional Pt(II) Reagents: Covalent Modifications of Pt Complexes Enable Diverse Structural Variation and In-Cell Detection.

  2016cites this paper
• Fluorescent Dansyl‐Guanosine Conjugates that Bind c‐MYC Promoter G‐Quadruplex and Downregulate c‐MYC Expression

  2016cites this paper
• Azide vs Alkyne Functionalization in Pt(II) Complexes for Post-treatment Click Modification: Solid-State Structure, Fluorescent Labeling, and Cellular Fate.

  2015cites this paper